NCT05547802View on ClinicalTrials.gov

Serology After BBIBP-CorV Inactivated Vaccine Combined With BNT62b2 mRNA Booster Vaccine

CompletedOBSERVATIONAL
Enrollment

122

Participants

Timeline

Start Date

November 16, 2021

Primary Completion Date

January 6, 2022

Study Completion Date

March 28, 2022

Conditions
Basic BBIBP-CorV Vaccination is Not as Effective as BNT162b
Interventions
BIOLOGICAL

BBIBP-CorV and/or BNT162b2 vaccine

Booster immunization was carried out at least 4 months after the first two doses of basic immunization.

Trial Locations (1)

4032

University of Debrecen, Debrecen

All Listed Sponsors
lead

University of Debrecen

OTHER

NCT05547802 - Serology After BBIBP-CorV Inactivated Vaccine Combined With BNT62b2 mRNA Booster Vaccine | Biotech Hunter | Biotech Hunter